Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Catriona Yale. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Catriona Yale har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AKRO / Akero Therapeutics, Inc. Chief Development Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Catriona Yale. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Catriona Yale som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-12-09 2025-12-09 4 AKRO Akero Therapeutics, Inc.
Common Stock
D - Sale to Issuer -47.573 0 -100,00
2025-12-09 2025-12-09 4 AKRO Akero Therapeutics, Inc.
Common Stock
D - Sale to Issuer -27.227 0 -100,00
2025-11-06 2025-11-04 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise 4.739 74.800 6,76 21,10 99.993 1.578.280
2025-11-06 2025-11-04 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise 3.527 70.061 5,30 28,35 99.990 1.986.229
2025-09-12 2025-09-11 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -659 90.829 -0,72 43,02 -28.350 3.907.464
2025-07-18 2025-07-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.342 91.488 -1,45 53,47 -71.762 4.892.229
2025-07-18 2025-07-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -8.658 92.830 -8,53 52,86 -457.705 4.907.458
2025-07-18 2025-07-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 101.488 10,93 19,87 198.700 2.016.567
2025-07-02 2025-06-30 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 890 91.488 0,98 23,87 21.243 2.183.636
2025-06-20 2025-06-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -895 92.231 -0,96 55,52 -49.690 5.120.573
2025-06-20 2025-06-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.895 93.126 -3,01 54,80 -158.643 5.103.212
2025-06-20 2025-06-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -6.210 96.021 -6,07 53,78 -333.974 5.164.009
2025-06-20 2025-06-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 102.231 10,84 21,10 211.000 2.157.074
2025-06-20 2025-06-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -1.633 90.598 -1,77 54,84 -89.554 4.968.394
2025-06-12 2025-06-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -2.803 92.231 -2,95 54,00 -151.351 4.980.105
2025-05-19 2025-05-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -4.384 95.034 -4,41 39,91 -174.948 3.792.427
2025-05-19 2025-05-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.779 99.418 -2,72 39,46 -109.659 3.923.034
2025-05-19 2025-05-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.837 102.197 -2,70 38,20 -108.371 3.903.823
2025-05-19 2025-05-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 105.034 10,52 21,10 211.000 2.216.217
2025-04-16 2025-04-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.200 95.034 -1,25 38,62 -46.339 3.669.833
2025-04-16 2025-04-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -7.873 96.234 -7,56 37,80 -297.623 3.637.934
2025-04-16 2025-04-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 9.073 104.107 9,55 21,10 191.440 2.196.658
2025-03-18 2025-03-17 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.799 95.034 -1,86 45,05 -81.045 4.281.282
2025-03-18 2025-03-17 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -8.201 96.833 -7,81 44,70 -366.560 4.328.145
2025-03-18 2025-03-17 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 105.034 10,52 21,10 211.000 2.216.217
2025-03-14 2025-03-12 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -614 95.034 -0,64 44,88 -27.556 4.265.126
2025-02-21 2025-02-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -900 95.648 -0,93 50,63 -45.571 4.843.041
2025-02-21 2025-02-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -9.100 96.548 -8,61 49,79 -453.089 4.807.125
2025-02-21 2025-02-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 105.648 10,46 21,10 211.000 2.229.173
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -8.700 95.648 -8,34 57,01 -495.961 5.452.606
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -14.467 104.348 -12,18 55,95 -809.429 5.838.271
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -25.907 118.815 -17,90 55,15 -1.428.823 6.552.885
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 49.074 144.722 51,31 21,10 1.035.461 3.053.634
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -27.340 95.648 -22,23 57,02 -1.559.036 5.454.232
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -9.250 122.988 -6,99 55,95 -517.528 6.881.056
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -17.000 132.238 -11,39 55,16 -937.652 7.293.719
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 21.569 149.238 16,89 21,09 454.890 3.147.429
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 15.172 127.669 13,49 6,36 96.555 812.486
2025-01-31 2025-01-27 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 16.849 112.497 17,62 0,62 10.362 69.186
2024-12-18 2024-12-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -9.074 95.648 -8,66 29,11 -264.117 2.784.026
2024-12-18 2024-12-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 9.074 104.722 9,49 21,10 191.461 2.209.634
2024-12-18 2024-12-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 24.300 95.648 34,06
2024-12-12 2024-12-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -2.810 71.348 -3,79 30,79 -86.520 2.196.805
2024-11-19 2024-11-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -300 74.158 -0,40 28,82 -8.647 2.137.456
2024-11-19 2024-11-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -8.761 74.458 -10,53 27,69 -242.627 2.062.040
2024-11-19 2024-11-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 9.061 83.219 12,22 21,10 191.187 1.755.921
2024-11-08 2024-11-06 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -10.000 74.158 -11,88 35,19 -351.890 2.609.546
2024-11-08 2024-11-06 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 84.158 13,48 0,62 6.150 51.757
2024-11-01 2024-11-01 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -15.485 74.158 -17,27 32,62 -505.105 2.418.960
2024-11-01 2024-11-01 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 15.485 89.643 20,88 21,10 326.734 1.891.467
2024-11-01 2024-10-30 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -4.515 74.158 -5,74 32,53 -146.855 2.412.063
2024-11-01 2024-10-30 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 4.515 78.673 6,09 21,10 95.266 1.660.000
2024-10-16 2024-10-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -300 75.294 -0,40 30,93 -9.278 2.328.618
2024-10-16 2024-10-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -14.525 75.594 -16,12 30,50 -442.954 2.305.315
2024-10-16 2024-10-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 14.825 90.119 19,69 0,62 9.117 55.423
2024-10-16 2024-10-14 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -6.136 74.158 -7,64 30,03 -184.258 2.226.891
2024-10-16 2024-10-14 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 80.294 6,64 0,62 3.075 49.381
2024-09-23 2024-09-20 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -5.500 75.294 -6,81 27,65 -152.086 2.082.030
2024-09-23 2024-09-20 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 5.500 80.794 7,30 0,62 3.382 49.688
2024-09-18 2024-09-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -3.871 75.294 -4,89 27,56 -106.685 2.075.103
2024-09-18 2024-09-18 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 3.871 79.165 5,14 0,62 2.381 48.686
2024-09-18 2024-09-17 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.037 75.294 -2,63 27,55 -56.115 2.074.199
2024-09-18 2024-09-17 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 2.037 77.331 2,71 0,62 1.253 47.559
2024-09-18 2024-09-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.485 75.294 -3,19 27,52 -68.375 2.071.714
2024-09-18 2024-09-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 2.485 77.779 3,30 0,62 1.528 47.834
2024-09-13 2024-09-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -637 75.294 -0,84 26,18 -16.677 1.971.197
2024-09-05 2024-09-03 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -949 75.931 -1,23 27,61 -26.206 2.096.759
2024-09-05 2024-09-03 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 949 76.880 1,25 0,62 584 47.281
2024-08-28 2024-08-26 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -5.200 75.931 -6,41 27,51 -143.073 2.089.166
2024-08-28 2024-08-26 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 5.200 81.131 6,85 0,62 3.198 49.896
2024-08-28 2024-08-23 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -8.851 75.931 -10,44 27,53 -243.641 2.090.153
2024-08-28 2024-08-23 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 8.851 84.782 11,66 0,62 5.443 52.141
2024-07-02 2024-06-28 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 1.064 75.931 1,42 19,94 21.217 1.514.140
2024-06-13 2024-06-11 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -2.825 74.867 -3,64 22,64 -63.961 1.695.064
2024-03-15 2024-03-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -723 77.692 -0,92 28,33 -20.483 2.201.014
2024-03-06 2024-03-04 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -20.646 78.415 -20,84 35,49 -732.727 2.782.948
2024-03-06 2024-03-04 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.646 99.061 12,04 21,09 224.524 2.089.196
2024-03-06 2024-03-04 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 10.000 88.415 12,75 6,36 63.600 562.319
2023-12-18 2023-12-14 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -597 77.910 -0,76 20,76 -12.394 1.617.412
2023-12-12 2023-12-08 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 32.497 78.507 70,63
2023-09-25 2023-09-21 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.200 46.010 -4,56 48,36 -106.387 2.224.938
2023-09-25 2023-09-21 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -2.800 48.210 -5,49 47,85 -133.969 2.306.660
2023-09-25 2023-09-21 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 51.010 10,87 6,36 31.800 324.424
2023-09-25 2023-09-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -617 46.010 -1,32 50,34 -31.060 2.316.143
2023-08-30 2023-08-28 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -500 46.627 -1,06 50,67 -25.335 2.362.590
2023-08-30 2023-08-28 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -5.245 47.127 -10,01 49,92 -261.856 2.352.806
2023-08-30 2023-08-28 4 AKRO Akero Therapeutics, Inc.
Common Stock
M - Exercise X 5.745 52.372 12,32 6,36 36.538 333.086
2023-06-23 2023-06-23 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -500 46.627 -1,06 51,41 -25.704 2.397.033
2023-06-23 2023-06-23 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -10.500 47.127 -18,22 50,73 -532.656 2.390.710
2023-06-23 2023-06-22 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -11.000 57.627 -16,03 52,18 -573.935 3.006.741
2023-06-23 2023-06-21 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -11.349 68.627 -14,19 52,26 -593.095 3.586.426
2023-06-15 2023-06-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -591 79.976 -0,73 55,16 -32.600 4.411.476
2023-03-14 2023-03-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
F - Taxes -701 80.567 -0,86 43,46 -30.465 3.501.442
2023-01-18 2023-01-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.105 81.268 -1,34 51,99 -57.446 4.224.880
2023-01-18 2023-01-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.313 82.373 -1,57 51,18 -67.197 4.215.718
2023-01-18 2023-01-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.534 83.686 -1,80 49,89 -76.531 4.175.103
2023-01-18 2023-01-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -1.048 85.220 -1,21 49,12 -51.476 4.185.896
2022-12-13 2022-12-12 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -402 86.268 -0,46 43,77 -17.596 3.775.950
2022-12-13 2022-12-12 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -4.598 86.670 -5,04 43,18 -198.542 3.742.411
2022-12-13 2022-12-09 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 19.195 91.268 26,63
2022-11-14 2022-11-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -100 72.073 -0,14 39,96 -3.996 2.880.037
2022-11-14 2022-11-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -4.900 72.173 -6,36 39,41 -193.109 2.844.338
2022-10-12 2022-10-10 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -5.000 77.073 -6,09 37,99 -189.950 2.928.003
2022-09-15 2022-09-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -13.986 82.073 -14,56 28,04 -392.167 2.301.327
2022-09-15 2022-09-13 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -26.014 96.059 -21,31 27,18 -707.061 2.610.884
2022-09-13 2022-06-30 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 1.152 122.073 0,95 8,03 9.251 980.246
2021-12-10 2021-12-08 4 AKRO Akero Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 87.221 87.221
2021-10-18 2021-10-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -100 120.921 -0,08 22,34 -2.234 2.701.375
2021-10-18 2021-10-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -12.400 121.021 -9,29 21,58 -267.592 2.611.633
2021-09-17 2021-09-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -2.000 133.421 -1,48 25,31 -50.620 3.376.886
2021-09-17 2021-09-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale -10.500 135.421 -7,20 24,57 -257.985 3.327.294
2021-08-17 2021-08-16 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -10.000 145.921 -6,41 18,79 -187.900 2.741.856
2021-07-19 2021-07-15 4 AKRO Akero Therapeutics, Inc.
Common Stock
S - Sale X -10.000 155.921 -6,03 20,90 -209.044 3.259.435
2020-12-09 2020-12-08 4 AKRO Akero Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 77.580 77.580
2020-12-09 2020-06-30 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 1.245 164.914 0,76 17,07 21.250 2.814.752
2020-01-03 2019-12-31 4 AKRO Akero Therapeutics, Inc.
Common Stock
A - Award 1.025 163.669 0,63 18,87 19.338 3.087.779
2019-12-13 2019-12-13 4 AKRO Akero Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 85.000 85.000
2019-06-19 3 AKRO Akero Therapeutics, Inc.
Common Stock
325.288
2019-06-19 3 AKRO Akero Therapeutics, Inc.
Common Stock
325.288
2019-06-19 3 AKRO Akero Therapeutics, Inc.
Common Stock
325.288
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)